Pyrazole derivatives as MALT1 inhibitors

Disclosed are compounds, compositions and methods for treating of diseases, syndromes, conditions, and disorders that are affected by the modulation of MALT1. Such compounds are represented by Formula (I) as follows:wherein R1, R2, R3, R4, R5, and G, are defined herein.

Saved in:
Bibliographic Details
Main Authors Lu, Tianbao, Edwards, James Patrick, Cummings, Maxwell David, Kreutter, Kevin D, Thuring, Jan Willem, Connolly, Peter J, Diels, Gaston Stanislas Marcella, Barbay, Joseph Kent, Wu, Tongfei, Philippar, Ulrike, Shen, Fang
Format Patent
LanguageEnglish
Published 22.06.2021
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:Disclosed are compounds, compositions and methods for treating of diseases, syndromes, conditions, and disorders that are affected by the modulation of MALT1. Such compounds are represented by Formula (I) as follows:wherein R1, R2, R3, R4, R5, and G, are defined herein.
Bibliography:Application Number: US201916440302